In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studies of substituted 1,2,4-oxadiazole analogues against Mycobacterium tuberculosis-Reference-Cited by-同舟云学术

In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studies of substituted 1,2,4-oxadiazole analogues against Mycobacterium tuberculosis

Published:2021-01-01 Issue:1 Volume:36 Page:869-884
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Deb Pran Kishore¹^ORCID,Al-Shar’i Nizar A.²^ORCID,Venugopala Katharigatta N.³⁴^ORCID,Pillay Melendhran⁵^ORCID,Borah Pobitra⁶^ORCID

Affiliation:

1. Department of Pharmaceutical Sciences, Faculty of Pharmacy, Philadelphia University, Amman, Jordan

2. Department of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan

3. Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, Kingdom of Saudi Arabia

4. Department of Biotechnology and Food Technology, Durban University of Technology, Durban, South Africa

5. Department of Microbiology, National Health Laboratory Services, KZN Academic Complex, Inkosi Albert Luthuli Central Hospital, Durban, South Africa

6. Pratiksha Institute of Pharmaceutical Sciences, Guwahati, India

Funder

Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14756366.2021.1900162

Reference118 articles.

1. Tuberculosis origin: The Neolithic scenario

2. Robert Koch: centenary of the discovery of the tubercle bacillus, 1882.